Skip to main content

Table 1 Stage I-IV patients’ characteristics and clinical features

From: The clinicopathological features and treatment modalities associated with survival of neuroendocrine cervical carcinoma in a Chinese population

Parameters

Group (no.)

MST (mo)

HR

P

FIGO

I-IIA (76)

60

  

IIB-IV(13)

30

2.629(1.201–5.727)

0.016

Size

4 cm (47)

65

  

>4 cm (42)

49

2.027(1.087–3.780)

0.026

LNM

No (50)

68

  

Yes(23)

44

2.573(1.269–5.216)

0.009

LVSI

No (46)

69

  

Yes(27)

46

2.443 (1.197–4.986)

0.014

DOI

2/3 (57)

67

  

>2/3(16)

51

2.165(0.931–5.035)

0.073

NACT

No (35)

60

  

Yes(38)

59

1.166(0.567–2.401)

0.676

Radiotherapy

No (66)

61

  

Yes(23)

37

1.345 (0.676–2.678)

0.398

Syn

No (8)

36

  

Yes(39)

58

1.671 (0.383–7.280)

0.494

CD56

No (12)

77

  

Yes(30)

52

1.844 (0.606–5.612)

0.281

CgA

No (15)

76

  

Yes(31)

50

1.933 (0.635–5.882)

0.246

NSE

No (6)

44

  

Yes (10)

55

0.837 (0.197–3.549)

0.809